Literature DB >> 12824458

The prevention of prostate cancer--the dilemma continues.

Peter T Scardino.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12824458     DOI: 10.1056/NEJMe038109

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  31 in total

Review 1.  The role of 5-alpha-reductase inhibition as monotherapy in view of the MTOPS data.

Authors:  Jaspreet S Sandhu; Alexis E Te
Journal:  Curr Urol Rep       Date:  2004-08       Impact factor: 3.092

2.  [Prevention of uro-oncological diseases].

Authors:  B J Schmitz-Dräger; G Lümmen; E Bismarck; C Fischer
Journal:  Urologe A       Date:  2012-05       Impact factor: 0.639

3.  Clinical pearls in men's health.

Authors:  Thomas J Beckman; Scott C Litin
Journal:  Mayo Clin Proc       Date:  2010-07       Impact factor: 7.616

Review 4.  Combination therapy for the pharmacological management of benign prostatic hyperplasia: rationale and treatment options.

Authors:  Jaspreet S Sandhu; E Darracott Vaughan
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

5.  Benign prostatic hyperplasia: caveat for finasteride should be discussed before prescribing.

Authors:  Hussam Ammar; Ashok K Malani; Chakshu Gupta
Journal:  BMJ       Date:  2006-09-23

6.  Finasteride therapy for benign prostatic hyperplasia.

Authors:  Thomas J Helling
Journal:  CMAJ       Date:  2008-02-26       Impact factor: 8.262

7.  [Chemoprevention of prostate cancer. Current status].

Authors:  B J Schmitz-Dräger; G Lümmen; R M Schäfer
Journal:  Urologe A       Date:  2007-06       Impact factor: 0.639

8.  [The Prostate Cancer Prevention Trial (PCPT). Relevance for clinical practice].

Authors:  B J Schmitz-Dräger; C Fischer; E Bismarck; H J Dörsam; G Lümmen
Journal:  Urologe A       Date:  2007-10       Impact factor: 0.639

9.  Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial.

Authors:  Joseph M Unger; Cathee Till; Ian M Thompson; Catherine M Tangen; Phyllis J Goodman; Jason D Wright; William E Barlow; Scott D Ramsey; Lori M Minasian; Dawn L Hershman
Journal:  J Natl Cancer Inst       Date:  2016-08-26       Impact factor: 13.506

Review 10.  Androgen replacement therapy: present and future.

Authors:  Louis J G Gooren; Mathijs C M Bunck
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.